Cell & Gene Therapy Manufacturing Services Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Cell & Gene Therapy Manufacturing Services Market Over The Period 2026–2030?
The cell & gene therapy manufacturing services market size has experienced significant growth in recent years. Projections indicate it will increase from $9.44 billion in 2025 to $11.08 billion in 2026, reflecting a compound annual growth rate (CAGR) of 17.4%. The expansion observed in the historic period is attributable to an escalating number of cell and gene therapy clinical candidates, the early outsourcing of manufacturing services, the broadening of academic translational research, limited in-house manufacturing capabilities, and a rising demand for specialized bioprocessing.
The cell & gene therapy manufacturing services market is expected to demonstrate substantial growth in the upcoming years. This market is set to expand to $21.05 billion by 2030, achieving a compound annual growth rate (CAGR) of 17.4%. The expansion during the forecast period is primarily driven by the escalating commercialization of cell and gene therapies, a rising need for large-scale manufacturing services, the broadening of personalized medicine pipelines, enhanced regulatory clarity for advanced therapies, and increasing investments in advanced therapy infrastructure. Significant trends anticipated for this period include the enlargement of gmp-compliant manufacturing capacity, a growing adoption of automated cell processing systems, an increasing demand for scalable viral vector production, the heightened integration of advanced quality control technologies, and a stronger focus on manufacturing standardization.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
Which Major Factors Are Driving The Expansion Of The Cell & Gene Therapy Manufacturing Services Market?
The prevalence of cancer and other specific diseases is set to advance the cell and gene therapy manufacturing services market in the coming period. Cancer is defined as a grave condition where the body’s cells multiply quickly and without control, resulting in abnormal growths. Cell and gene therapies are developing as effective new methods to combat the rising occurrence of cancer, which is consequently stimulating demand for innovative and efficient treatment alternatives. For instance, in February 2025, the American Cancer Society, a US-based nonprofit cancer advocacy organization, estimated that 316,950 new cases of invasive breast cancer would be diagnosed in women and 2,800 cases in men in the US in 2025. Thus, the high incidence of cancer and other target diseases is a key factor driving the growth of the cell and gene therapy manufacturing services market.
How Is The Cell & Gene Therapy Manufacturing Services Market Divided Into Its Major Segments?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Which Trends Are Shaping The Future Of The Cell & Gene Therapy Manufacturing Services Market?
Major companies within the cell and gene therapy manufacturing services market are concentrating on creating advanced biomanufacturing technologies to improve scalability, production efficiency, and the overall quality of cell and gene therapies. As an example, in September 2025, ARPA-H, a US-based government health agency, initiated a program aimed at stimulating innovative biomanufacturing for cell and gene therapies. This program’s objective is to hasten the development of sophisticated manufacturing platforms, increase production yields, and facilitate the affordable, scalable production of complex cell and gene therapy products. By backing high-risk, high-reward technologies, this initiative is expected to fuel innovation in biomanufacturing, reinforce the manufacturing ecosystem, and provide patients with faster access to groundbreaking therapies.
Who Are The Prominent Organizations Shaping The Cell & Gene Therapy Manufacturing Services Market?
Major companies operating in the cell & gene therapy manufacturing services market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Fujifilm Holdings Corporation, Oxford Biomedica plc, Cell and Gene Therapy Catapult, Samsung Biologics Co. Ltd., BioNTech SE, Novartis International AG, Pfizer Inc., Boehringer Ingelheim International GmbH, Sarepta Therapeutics Inc., bluebird bio Inc., Precision BioSciences Inc., GSK plc, AstraZeneca plc, Bayer AG
Read the full cell & gene therapy manufacturing services market report here:
Which Region Currently Holds The Largest Share Of The Cell & Gene Therapy Manufacturing Services Market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cell & Gene Therapy Manufacturing Services Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp
Browse Through More Reports Similar to the Global Cell & Gene Therapy Manufacturing Services Market 2026, By The Business Research Company
Next Generation Antibody Therapeutics Global Market Report
Monoclonal Antibodies Global Market Report
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report
Polyclonal Antibodies Global Market Report
https://www.thebusinessresearchcompany.com/report/polyclonal-antibodies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
